Hill Dermaceuticals, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 2650 SOUTH MELLONVILLE AVENUE, SANFORD, Florida (FL) 32773, United States (USA)
- Operations here
- analysislabelmanufacturepackrelabelrepack
- FDA identifiers
- FEI 1036365 · DUNS 098366990
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-10-14
- VAIDrug Quality Assurance2021-08-11
- VAIDrug Quality Assurance2018-05-18
- VAIDrug Quality Assurance2014-10-06
- OAIDrug Quality Assurance2012-08-10
- OAIDrug Quality Assurance2012-03-30
- OAIDrug Quality Assurance2010-09-10
- NAIBioresearch Monitoring2010-02-19
- OAIDrug Quality Assurance2010-02-19
Drugs this plant is listed as making
4 distinct drugs across 4 products name this site in their FDA label.
- fluocinolone acetonideRoyal Pharmaceuticals
- fluocinolone acetonide, hydroquinone, and tretinoinGalderma Laboratories, L.P.
- FluorouracilHill Dermaceuticals, Inc.
- IvermectinMayne Pharma Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.